FIELD: medicine.
SUBSTANCE: composition contains the compound blocking the cyclic state G1, and the antiviral agent that inhibits or reduces HIV penetration into mononuclear cells. The compound blocking the cyclic state G1 is chosen from the group consisting of sodium butyrate, afidicoline, olomucine, roscovitine, tocopherols, tocotrienols, hydroxyurea and rapamycine.
EFFECT: invention ensures reducing receptor site number for HIV penetration into T-cages and increasing in antiviral agent activity.
14 cl, 9 dwg, 9 ex
